Article

Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients

2021-10-07

Abstract excerpt

Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is required to guide prophylactic and therapeutic COVID-19 interventions in this frail population. By analyzing plasma samples from 130 hemodialysis and 13 peritoneal dialysis patients after two doses of BNT162b2 or mRNA-1273 vaccines,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b56718b3-accf-5178-9e9b-ca4fa4be8e13
DOI: 10.1101/2021.10.05.21264054

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patientsDOI 10.1101/2021.10.05.21264054Read

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysisSemantic proximity Read

Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patientsSemantic proximity Read

Diminishing immune responses against variants of concern in dialysis patients four months after SARS-CoV-2 mRNA vaccinationSemantic proximity Read

Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational studySemantic proximity Read

Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of break-through infections in hemodialysis patientsSemantic proximity Read

Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative StudySemantic proximity Read

A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort studySemantic proximity Read

Improved SARS-CoV-2 neutralization of Delta and Omicron variants of concern after fourth vaccination in hemodialysis patientsSemantic proximity Read

Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort studySemantic proximity Read

Impaired antigen-specific memory B cell and plasma cell responses including lack of specific IgG upon SARS-CoV-2 BNT162b2 vaccination among Kidney Transplant and Dialysis patientsSemantic proximity Read

Risk Factors for Low Humoral Response to BNT-162b2 In Hemodialysis PatientsSemantic proximity Read

Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case ReportSemantic proximity Read